Beroni Group Sets Up a New R&D Centre in High-Tech Hub in Zhuhai, China
NEW YORK and SYDNEY, Australia, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the...
Year: 2022
Ozop Energy Solutions Receives Department of Insurance Approval
EV Insurance Company, Inc. DBA OZOP Plus Preparing for Launch Florida, NY, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Ozop Energy...
Celsion Corporation Advances Proof of Concept to Non-human Primate Challenge Study Against SARS-CoV-2 with In-Process Vaccine Candidate
Preclinical results demonstrate safe and efficient immune response with vaccine development showing promise of neutralizing activity for a range of...
Franciscan Health Achieves Center of Excellence Status for Cardio-Oncology Care
Franciscan Health Franciscan Health Indianapolis INDIANAPOLIS, Indiana, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Franciscan Health joins an elite group of...
Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Date
BATON ROUGE, La., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice,...
ImmixBio Initiates IMX-110 GMP Manufacturing Scale-Up, Potentially Accelerating Clinical Trial Data
ImmixBio Initiates IMX-110 GMP Manufacturing Scale-Up, Potentially Accelerating Clinical Trial Data Immix Biopharma, Inc. (NASDAQ:IMMX) Manufactured IMX-110 to be utilized...
Brain Scientific Issues Shareholder Letter and Corporate Update
New CEO foresees revenue growth from commercial medical product launches in $4 billion addressable marketNEW YORK, Jan. 31, 2022 (GLOBE...
Immutep to Present at February Investor Conferences
SYDNEY, AUSTRALIA, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology...
Keros Therapeutics Appoints Christopher Rovaldi as Chief Operating Officer
LEXINGTON, Mass., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on...
Universe Pharmaceuticals INC Reports Fiscal Year 2021 Financial Results
Ji’an, Jiangxi, China, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and...
180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Shareholders
PALO ALTO, Calif., Jan. 31, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF, “180 Life Sciences” or the "Company"),...
Zenith Epigenetics Announces Appointment to Board of Directors and Provides Clinical Update
CALGARY, Alberta, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith” or the “Company”) today announced the appointment of...
Medexus Schedules Third Quarter Fiscal 2022 Conference Call
TORONTO and CHICAGO, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF)...
Spectral Medical Announces U.S. FDA Approval of DIMI Trial Protocol Amendment
Amendment expected to overcome key pandemic challenges and improve both site and patient enrollmentTORONTO, Jan. 31, 2022 (GLOBE NEWSWIRE) --...
Elusys Therapeutics Finalizes HHS Contract to Deliver ANTHIM®, Its Treatment for Inhalation Anthrax, to the U.S. Department of Health and Human Services
Completed first phase of contract for $50 million; HHS options to procure up to $31 million of ANTHIM by the...
Olema Oncology Appoints Naseem Zojwalla, M.D., as Chief Medical Officer
• Dr. Zojwalla brings extensive and diverse experience in clinical development and regulatory strategy for novel oncology therapies • As part...
BrainsWay Announces Final Local Coverage Determination Issued by Regional Medicare Administrative Contractor Palmetto GBA Providing Coverage of Deep TMS™ for the Treatment of OCD
Palmetto GBA Covers Medicare Patients in Seven StatesBURLINGTON, Mass. and JERUSALEM, Jan. 31, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ...
Quipt Announces Revocation of Management Cease Trade Order
CINCINNATI, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based...
Humacyte Announces Clinical Case Series Demonstrating Potential of Human Acellular Vessel™ (HAV™) to Expand Opportunities for Limb Salvage in Multiple Complex Vascular Reconstruction Scenarios
– Outcomes of first eight compassionate use cases presented at 46th Annual Winter Meeting of the Vascular and Endovascular Surgery Society...
Biogen Announces Nancy Leaming and Brian Posner to Retire from Board of Directors
CAMBRIDGE, Mass., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that Nancy Leaming and Brian Posner...
